| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 574 |
| 1 | METHOTREXATE SODIUM | 142 |
| 2 | METHOTREXATE | 137 |
| 3 | ETANERCEPT | 116 |
| 4 | HYDROXYCHLOROQUINE SULFATE | 91 |
| 5 | LEFLUNOMIDE | 88 |
| 6 | INFLIXIMAB | 83 |
| 7 | TOCILIZUMAB | 78 |
| 8 | ABATACEPT | 75 |
| 9 | RITUXIMAB | 68 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUORESCEIN SODIUM | 5 | 0.0162 |
| 1 | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | 3 | 0.0076 |
| 2 | CLINDAMYCIN PHOSPHATE | 18 | 0.0033 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 8 | 0.0029 |
| 4 | PRUCALOPRIDE SUCCINATE | 1 | 0.0029 |
| 5 | GAS RELIEF | 1 | 0.0020 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | 1 | 0.0018 |
| 7 | ESTRADIOL CYPIONATE | 1 | 0.0017 |
| 8 | HYDROQUINONE | 1 | 0.0017 |
| 9 | ELAGOLIX AND ESTRADIOL AND NORETHISTERONE | 1 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 137 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 131 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 123 |
| 3 | Antirheumatic Agent [EPC] | 88 |
| 4 | Corticosteroid [EPC] | 82 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 78 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 75 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 69 |
| 8 | Vitamin C [EPC] | 67 |
| 9 | Vitamin D [EPC] | 56 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Provitamin D2 Compound [EPC] | 44 | 0.0015 |
| 3 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 4 | Antirheumatic Agent [EPC] | 88 | 0.0008 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 4 | 0.0006 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 78 | 0.0006 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 75 | 0.0005 |
| 8 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 3 | 0.0005 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |